Compare NEOG & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | CLDX |
|---|---|---|
| Founded | 1981 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 1995 | 1995 |
| Metric | NEOG | CLDX |
|---|---|---|
| Price | $9.24 | $33.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $10.67 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 2.5M | 725.4K |
| Earning Date | 04-09-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $894,661,000.00 | $12,743,000.00 |
| Revenue This Year | N/A | $111.39 |
| Revenue Next Year | N/A | $235.85 |
| P/E Ratio | $459.00 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $4.53 | $18.20 |
| 52 Week High | $11.43 | $35.83 |
| Indicator | NEOG | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 53.45 |
| Support Level | $8.98 | $28.30 |
| Resistance Level | $10.12 | $35.18 |
| Average True Range (ATR) | 0.36 | 1.32 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 26.02 | 40.19 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.